Singapore markets closed

Viatris Inc. (VTRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.71+0.24 (+2.29%)
At close: 04:00PM EDT
10.58 -0.13 (-1.21%)
After hours: 07:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.47
Bid10.47 x 900
Ask10.70 x 21500
Day's range10.28 - 10.74
52-week range9.66 - 15.60
Avg. volume11,537,391
Market cap12.984B
Beta (5Y monthly)1.28
PE ratio (TTM)76.50
EPS (TTM)0.14
Earnings date08 Aug 2022
Forward dividend & yield0.48 (4.48%)
Ex-dividend date23 May 2022
1y target est16.39
  • Zacks

    Viatris (VTRS) Up 13.7% Since Last Earnings Report: Can It Continue?

    Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Motley Fool

    2 Bruised Dividend Stocks to Buy While They're Cheap

    Downturns are a great time to load up on high-quality dividend stocks. Falling share prices pump up dividend yields, and that means you'll get more bang for your buck in the long run, assuming that the stocks you buy eventually return to growth. Viatris (NASDAQ: VTRS) manufactures a smorgasbord of common generic drugs and it also produces reputable brands like EpiPens, Viagra, and Lipitor.

  • Motley Fool

    Why Shares of Viatris Climbed 18.8% in May

    Shares of Viatris (NASDAQ: VTRS), a biopharmaceutical company known for its branded, generic, and biosimilar therapies, saw its shares rise 18.8% in May, according to data provided by S&P Global Market Intelligence.